DELANEY MARK E
SVP & Chief Commercial Officer
DELANEY MARK E has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 6 of those filings fall inside the rolling window. Most recent filing: Jul 29, 2026.
On the most recent filing, DELANEY MARK E is listed as SVP & Chief Commercial Officer at QUEST DIAGNOSTICS INC. Inside the rolling window, DELANEY MARK E reported no open-market purchases and 2 open-market sales totaling $1.9M in DGX. The largest disclosed transaction in the window is a sale of 7,946 DGX shares on Nov 18, 2025, worth $1.5M.
Companies traded
Other insiders at DGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has DELANEY MARK E made?
DELANEY MARK E has filed 6 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does DELANEY MARK E trade?
DELANEY MARK E has filed SEC Form 4 disclosures for 1 company, including DGX.
When was DELANEY MARK E's most recent SEC Form 4 filing?
DELANEY MARK E's most recent SEC Form 4 filing on Tracefour is dated Jul 29, 2026.
What is DELANEY MARK E's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, DELANEY MARK E is listed as SVP & Chief Commercial Officer.
What is DELANEY MARK E's total buy and sell value in the current window?
Inside the rolling retention window, DELANEY MARK E bought $0 and sold $1.9M based on SEC Form 4 filings.
What was DELANEY MARK E's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,946 DGX shares on 2025-11-18, worth $1.5M, per SEC Form 4 filings.